Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs) EQUITY
$169.54
neg -3.25
-1.88%
Today's Range: 167.79 - 173.95 | ILMN Avg Daily Volume: 1,232,400
Last Update: 08/24/16 - 4:00 PM EDT
Volume: 1,022,127
YTD Performance: -9.98%
Open: $173.21
Previous Close: $172.79
52 Week Range: $127.10 - $213.27
Oustanding Shares: 146,600,000
Market Cap: 25,471,750,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 3 5 5
Moderate Buy 0 1 1 0
Hold 10 9 11 11
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
Mean Rec. 2.55 2.59 2.35 2.38
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 59.50
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
59.50 59.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
23.57% -13.58% 117.87%
GROWTH 12 Mo 3 Yr CAGR
Revenue 19.30 0.90 0.24
Net Income 29.40 2.00 0.44
EPS 30.80 1.60 0.37
Earnings for ILMN:
EBITDA 0.79B
Revenue 2.22B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.91 $1.05 $3.54 $4.07
Number of Analysts 9 8 10 10
High Estimate $0.94 $1.09 $3.58 $4.30
Low Estimate $0.88 $0.99 $3.50 $3.95
Prior Year $0.80 $0.81 $3.32 $3.54
Growth Rate (Year over Year) 14.17% 29.32% 6.54% 15.04%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Lots of energy names facing the potential for lower prices.
Bearish
Jul 05, 2016 | 7:08 AM EDT
ILMN was downgraded to Underweight, Morgan Stanley said. $110 price target. Company is facing end-market pressures. 
Bearish
Apr 19, 2016 | 7:10 AM EDT
ILMN was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $180 price target. Company is struggling to execute in Eur...
Bearish
Apr 19, 2016 | 6:57 AM EDT
ILMN was downgraded from Buy to Hold, Cantor Fitzgerald said. $165 price target. Company lacks near-term visibility. 
Following the positive action over the last four days, an upside resolution now appears likely. 
Bearish
Feb 04, 2016 | 6:57 AM EST
ILMN was downgraded to Hold, Canaccord Genuity said. Valuation call, based on a $160 price target. 
Bearish
Jan 07, 2016 | 7:23 AM EST
ILMN was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as the stock is valued at 48x expected 2016 ea...

This Laggard Is Set to Shine Real Money Pro($)

Illumina is moving toward higher ground.
Charts show ILMN is close to offering a great profit opportunity.

Novice Trade: Illumina Real Money Pro($)

ILMN's three-month at-the-money implied volatility is at about the median level.

Columnist Conversations

AMZN is beginning to look vulnerable to a healthy pullback.  The stock has worked off all of its late Jul...
The SMH looks completely exhausted.  Since the Aug.
Out in San Francisco for the Money Show and about to do presentation on biotech investing, but thought I would...
Enormous flow in SBUX this week, notably the Nov 57.5 strike, was more popular than a ticket to see Hamilton.&...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.